Oxford Pharmaceutical Sciences

Oxford Pharmaceutical Sciences (OPS) was a prominent UK-based Contract Research Organization (CRO) that specialized in biometrics, biostatistics, and clinical data management for the pharmaceutical and biotechnology industries. The company was recognized for its high-level statistical expertise and its role in providing data-driven insights for clinical trial development. In 2007, Oxford Pharmaceutical Sciences merged with Statwood Ltd to form Quanticate, which has since grown into one of the world's largest data-focused CROs. The merger allowed the combined entity to offer a more comprehensive suite of biometric services on a global scale. OPS's legacy remains a foundational part of Quanticate's reputation for statistical excellence in life sciences research.